Atlas Trials

Deaf Blind

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Deaf Blind

RecordFirmDate
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) (NCT05176717)Laboratoires Thea2021-12-15
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) (NCT05158296)Laboratoires Thea2021-12-08
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (NCT03780257)ProQR Therapeutics2019-03-06

Track Deaf Blind automatically

Every clearance here is in the API, with alerts when new ones post.